Antiviral RNA interference in mammalian cells - PubMed (original) (raw)
Antiviral RNA interference in mammalian cells
P V Maillard et al. Science. 2013.
Abstract
In antiviral RNA interference (RNAi), the DICER enzyme processes virus-derived double-stranded RNA (dsRNA) into small interfering RNAs (siRNAs) that guide ARGONAUTE proteins to silence complementary viral RNA. As a counterdefense, viruses deploy viral suppressors of RNAi (VSRs). Well-established in plants and invertebrates, the existence of antiviral RNAi remains unknown in mammals. Here, we show that undifferentiated mouse cells infected with encephalomyocarditis virus (EMCV) or Nodamura virus (NoV) accumulate ~22-nucleotide RNAs with all the signature features of siRNAs. These derive from viral dsRNA replication intermediates, incorporate into AGO2, are eliminated in Dicer knockout cells, and decrease in abundance upon cell differentiation. Furthermore, genetically ablating a NoV-encoded VSR that antagonizes DICER during authentic infections reduces NoV accumulation, which is rescued in RNAi-deficient mouse cells. We conclude that antiviral RNAi operates in mammalian cells.
Figures
Fig. 1. EMCV-derived siRNAs in infected mESCs
(A) Western analysis of VP1 in E14 mESCs. NI, noninfected; ACTIN, protein-loading control. (B) Size distribution of vsRNA reads mapping to EMCV in samples from (A). (C) Distributions of 21- to 23-nt and 24- to 44-nt reads along EMCV (+) and (−) strands 6 hpi. (D) Same as (C), but along the first 5′-terminal 300 nt. Symmetrical reads are numbered. (Inset) Perfect duplexes formed by the abundant reads 1 to 2 and 3 to 4; 2-nt 3′ overhangs are indicated in red. Asterisk: Read sequence corresponding to the oligonucleotide probe used in (E). Radar plots: 21- and 23-nt reads in each of 22 possible registers mapping along the entire EMCV (+) and (−) strands; the 5′ first EMCV nucleotide defines register no. 1. Distance to the center indicates read percentage within each register. (E) Northern analysis of EMCV 5′-end siRNAs 6 hpi. Total RNA from SUC-SUL (SS) transgenic Arabidopsis run in parallel and hybridized secondarily provides a size marker for 21-nt and 24-nt siRNAs. U6, RNA-loading controls.
Fig. 2. AGO2-loaded EMCV siRNAs are reduced in Dcr−/− mESCs and following differentiation
(A) Western and Northern analysis of VP1 (top), EMCV 5′-end siRNAs (middle) and miR-16/pre-miR-16 (bottom) in DcrFlx/Flx and _Dcr_−/− mESCs infected (+) or not (−) with EMCV. SS, as in Fig. 1E. ACTIN and U6: protein- and RNA-loading controls. (B) Northern analysis of EMCV 5′-end siRNAs 6 hpi in FLAG-specific immunoprecipitates isolated from WT mESCs or mESCs stably expressing human FLAG-HA hAGO2, infected (+) or not (−) with EMCV. SS as in (A). Western analyses show comparable infection levels (VP1) and confirm FHA-hAGO2 immunoprecipitation with miR-16. Total: Coomassie-stained protein loading control. (C) Distributions of 21- and 23-nt reads along EMCV (+) and (−) strands after deep-sequencing of RNA from endogenous mAGO2 IP 6 hpi. Asterisks: reads further analyzed in fig. S2E. (D) Same as (C), but along the first 5′-terminal 150 nt. (E) Western and Northern analyses of the pluripotency markers OCT4, VP1, EMCV 5′-end siRNAs and miR-16 in undifferentiated mESCs on day 0 (d0) or after 10 days of differentiation (d10), infected (+) or not (−) with EMCV. Total as in (B); U6 and SS are as above. (F) Size distribution of vsRNA deep-sequencing reads mapping to EMCV in samples from (E). Abundance was normalized to the total number of reads mapping to EMCV. (G) Reads mapping to EMCV in infected day 0 and day 10 mESCs, as in Fig. 1D. Note the scale change in counts, highlighted in red. (Inset) siRNA duplex 1 to 2 remains detectable in day 10 cells.
Fig. 3. B2 antagonizes NoV-derived siRNA production
(A) Northern analysis of genomic RNA1 and subgenomic (sg)RNA3 in mESCs 72 hpi with NoV or NoVΔB2. Ribosomal RNA (rRNA) indicates rRNA ethidium bromide staining; NI, noninfected.(B)Normalized size distribution of deep-sequencing reads mapping the NoV or NoVΔB2 genome in samples from (A). (C) Distributions of 21- to 23-nt and 24- to 44-nt reads along the (+) and (−) strands of NoV (left) or NoVΔB2 (right) RNA1. (D) Same as (C), but along the first 5′-terminal 300 nt. (E) Radar plots as in Fig. 1D, but for NoV and NoVΔB2; RNA1 5′ first nucleotide defines register no. 1. (F) Read sequences along the first 180 nt of the 5′-terminus of NoVΔB2 RNA1 (+) and (−) strands. Read counts (in bold italic), genomic position, and sequence variants are indicated. Nonsequenced reads within the main ~22-nt vsRNA periodicity register are indicated with XXX. Reads detected identically in NoVΔB2-infected BHK-21 cells and suckling mice (23) are depicted in blue. 2-nt3′ overhangs are in red.
Fig. 4. Rescue of NoVΔB2 accumulation in AGO2-deficient mESCs
(A) Quantitative reverse transcription polymerase chain reaction (RT-PCR) analysis of the hAgo2 transgene mRNA levels in noninfected (NI) and NoV- and NoVΔB2-infected E7 mESCs previously treated (+) or not (−) with tamoxifen for 5 days. Results show the mean and standard deviation of two independent experiments; a.u., arbitrary units. (B) Relative accumulation of NoV or NoVΔB2 RNA1 72 hpi in E7 mESC treated (+T) or not with tamoxifen, assessed by quantitative RT-PCR on samples used in (A). Results show the mean of the ratio and the standard deviation calculated from two independent experiments. (C) Northern analysis of NoV and NoVΔB2 genomic RNA1 and sgRNA3 72 hpi of the cells used in (A). rRNA, as in Fig. 3A.
Comment in
- Molecular biology. RNAi, Antiviral after all.
Sagan SM, Sarnow P. Sagan SM, et al. Science. 2013 Oct 11;342(6155):207-8. doi: 10.1126/science.1245475. Science. 2013. PMID: 24115433 No abstract available. - Small RNAs: antiviral RNAi in mammals.
Burgess DJ. Burgess DJ. Nat Rev Genet. 2013 Dec;14(12):821. doi: 10.1038/nrg3616. Epub 2013 Oct 22. Nat Rev Genet. 2013. PMID: 24145213 No abstract available. - Antiviral RNA interference in animals: piecing together the evidence.
Tanguy M, Miska EA. Tanguy M, et al. Nat Struct Mol Biol. 2013 Nov;20(11):1239-41. doi: 10.1038/nsmb.2708. Nat Struct Mol Biol. 2013. PMID: 24197164 No abstract available.
Similar articles
- Mechanism and Function of Antiviral RNA Interference in Mice.
Han Q, Chen G, Wang J, Jee D, Li WX, Lai EC, Ding SW. Han Q, et al. mBio. 2020 Aug 4;11(4):e03278-19. doi: 10.1128/mBio.03278-19. mBio. 2020. PMID: 32753500 Free PMC article. - Small RNAs: antiviral RNAi in mammals.
Burgess DJ. Burgess DJ. Nat Rev Genet. 2013 Dec;14(12):821. doi: 10.1038/nrg3616. Epub 2013 Oct 22. Nat Rev Genet. 2013. PMID: 24145213 No abstract available. - Molecular biology. RNAi, Antiviral after all.
Sagan SM, Sarnow P. Sagan SM, et al. Science. 2013 Oct 11;342(6155):207-8. doi: 10.1126/science.1245475. Science. 2013. PMID: 24115433 No abstract available. - RNA-based viral immunity initiated by the Dicer family of host immune receptors.
Aliyari R, Ding SW. Aliyari R, et al. Immunol Rev. 2009 Jan;227(1):176-88. doi: 10.1111/j.1600-065X.2008.00722.x. Immunol Rev. 2009. PMID: 19120484 Free PMC article. Review. - Mammalian viral suppressors of RNA interference.
Li WX, Ding SW. Li WX, et al. Trends Biochem Sci. 2022 Nov;47(11):978-988. doi: 10.1016/j.tibs.2022.05.001. Epub 2022 May 23. Trends Biochem Sci. 2022. PMID: 35618579 Free PMC article. Review.
Cited by
- RNAi-Induced Gene Silencing against Chikungunya and COVID-19: What Have We Learned So Far, and What Is the Way Forward?
Panda K, Alagarasu K, Tagore R, Paingankar M, Kumar S, Jeengar MK, Cherian S, Parashar D. Panda K, et al. Viruses. 2024 Sep 20;16(9):1489. doi: 10.3390/v16091489. Viruses. 2024. PMID: 39339965 Free PMC article. Review. - Protein-coding circular RNA enhances antiviral immunity via JAK/STAT pathway in Drosophila.
Guo D, Xu W, Cui T, Rong Q, Wu Q. Guo D, et al. mBio. 2024 Sep 11;15(9):e0146924. doi: 10.1128/mbio.01469-24. Epub 2024 Aug 19. mBio. 2024. PMID: 39158293 Free PMC article. - Functional canonical RNAi in mice expressing a truncated Dicer isoform and long dsRNA.
Buccheri V, Pasulka J, Malik R, Loubalova Z, Taborska E, Horvat F, Roos Kulmann MI, Jenickova I, Prochazka J, Sedlacek R, Svoboda P. Buccheri V, et al. EMBO Rep. 2024 Jul;25(7):2896-2913. doi: 10.1038/s44319-024-00148-z. Epub 2024 May 20. EMBO Rep. 2024. PMID: 38769420 Free PMC article. - Live-attenuated virus vaccine defective in RNAi suppression induces rapid protection in neonatal and adult mice lacking mature B and T cells.
Chen G, Han Q, Li WX, Hai R, Ding SW. Chen G, et al. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2321170121. doi: 10.1073/pnas.2321170121. Epub 2024 Apr 17. Proc Natl Acad Sci U S A. 2024. PMID: 38630724 Free PMC article. - Antiviral Defence Mechanisms during Early Mammalian Development.
Mueller F, Witteveldt J, Macias S. Mueller F, et al. Viruses. 2024 Jan 24;16(2):173. doi: 10.3390/v16020173. Viruses. 2024. PMID: 38399949 Free PMC article. Review.
References
- Chalupnikova K, Nejepinska J, Svoboda P. Methods Mol Biol. 2013;942:291–314. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials